Kidney transplantation using lymphocyte depleting induction and standard maintenance immunosuppression at the height of the SARS‐CoV‐2 pandemic in New York City: A single‐center experience

• Published in: Clinical transplantation Vol. 34; no. 9; pp. e14055 - n/a
• Main Authors: Santeusanio, Andrew D., Zendel, Alexey, Fenig, Yaniv, Mahamid, Ahmad, Bhansali, Arjun, De Boccardo, Graciela, Delaney, Veronica, Farouk, Samira S., Dunn, Dallas, Rana, Meenakshi, Florman, Sander, Shapiro, Ron
• Format: Journal Article
• Language: English
• Published: Denmark 01.09.2020
• Subjects: Adult; Aged; COVID-19 - complications; COVID-19 - mortality; COVID-19 - therapy; COVID‐19; Female; Graft Rejection; Graft Survival; Humans; immunosuppressive agents; Kidney Failure, Chronic - complications; Kidney Failure, Chronic - mortality; Kidney Failure, Chronic - surgery; Kidney Transplantation; Lymphocyte Depletion; Male; Middle Aged; New York City - epidemiology; Retrospective Studies; SARS-CoV-2; Survival Rate; transplant recipients; New York City; immunosuppressive agents; transplant recipients; COVID‐19; kidney transplantation

Background Concerns have been raised regarding proceeding with kidney transplantation using standard immunosuppression in COVID‐19 endemic areas. Methods We performed a single‐center review of all adult kidney transplants performed during the COVID‐19 pandemic in New York City. Patients were managed...